Home » Services » Drug efficacy and characterisation

Drug efficacy and characterisation

We offer a wide range of tests tailored to the needs of our customers for the research and development of active pharmaceutical ingredients (APIs) and products. For this purpose, we have state-of-the-art tools and equipment at our disposal.

We are able to support all stages of pharmaceutical development, from pre-clinical studies to clinical phases through in vitro and ex vivo physiological models:

Skin: Studies for the development and characterisation of products for topical use on human skin explants and reconstituted models. We work with healthy skin as well as with pathologies and lesions.
Digestive system: In vitro evaluations of the effect of stomach and intestinal digestive processes on an API. We determine absorption across the intestinal barrier.
Blood: Research into different blood populations in healthy individuals and those with pathologies. Analysis of the activity of compounds in the total blood population or in purified and/or differentiated subtypes.
Respiratory system: Studies of candidates in healthy or pathological human nasal/pulmonary epithelium. We evaluate the response of the epithelium to prolonged exposure to single or repeated doses of the products.
Central Nervous System: Product evaluation through modelling of human neurological pathologies and disorders in organoids. Assessment of the blood-brain barrier passage potential of APIs.

Documentation

Would you like to talk to an expert?

Miguel Romano

Biotechnology Market Manager

Drug efficacy and characterisation

Documentation

Would you like to talk to an expert?

Miguel Romano

Would you like to keep up to date with our news?

Member of: